Company Search:
Advanced Search
Sponsored Links
Sienna Cancer Diagnostics Ltd Company Snapshot
Sienna Cancer Diagnostics Ltd operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sienna Cancer Diagnostics Ltd with three other pharmaceutical manufacturers in Australasia: Auscann Group Holdings Ltd (2019 sales of 861,770.00 Australian Dollars [US$595,965.66 ] ), MGC Pharmaceuticals Ltd (858,087.00 Australian Dollars [US$593,418.65 ] ), and Orthocell Ltd (956,472.00 Australian Dollars [US$661,457.78 ] ).

Sales Analysis. During the year ended June of 2019, sales at Sienna Cancer Diagnostics Ltd were A$1.18 million (US$818.59 thousand). This is a decrease of 8.6% versus 2018, when the company's sales were A$1.30 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sienna Cancer Diagnostics Ltd
  Stock Performance Chart for Sienna Cancer Diagnostics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): .07
(Figures in Australian Dollars)
1 Week -1.4%   13 Weeks -10.5%  
4 Weeks 209.1%   52 Weeks 4.6%  
Sienna Cancer Diagnostics Ltd Key Data:
  Ticker: SDX Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2019 Sales 1,183,685
(Year Ending Jan 2020).
Employees: N/A
  Currency: Australian Dollars Market Cap: 23,393,368
  Fiscal Yr Ends: June Shares Outstanding: 344,020,124
  Share Type: STAMMAKTIE Closely Held Shares: 154,830,871
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.